Iron(III)-salophene catalyzes redox cycles that induce phospholipid peroxidation and deplete cancer cells of ferroptosis-protecting cofactors
-
Published:2024-09
Issue:
Volume:75
Page:103257
-
ISSN:2213-2317
-
Container-title:Redox Biology
-
language:en
-
Short-container-title:Redox Biology
Author:
Su Fengting,
Descher Hubert,
Bui-Hoang Minh,
Stuppner Hermann,
Skvortsova Ira,
Rad Ehsan Bonyadi,
Ascher Claudia,
Weiss Alexander,
Rao Zhigang,
Hohloch Stephan,
Koeberle Solveigh C.,
Gust Ronald,
Koeberle AndreasORCID
Reference105 articles.
1. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications;Stockwell;Cell,2022
2. Ferroptosis-modulating small molecules for targeting drug-resistant cancer: challenges and opportunities in manipulating redox signaling;Koeberle;Med. Res. Rev.,2023
3. The therapeutic potential of targeting regulated non-apoptotic cell death;Hadian;Nat. Rev. Drug Discov.,2023
4. RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer;Xu;Redox Biol.,2023
5. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy;Gao;Signal Transduct. Targeted Ther.,2022